Alcoholic hepatitis: How far are we and where are we going?

Verónica Prado, Joan Caballería, Víctor Vargas, Ramón Bataller, José Altamirano

Research output: Contribution to journalReview articleResearchpeer-review

11 Citations (Scopus)


© 2016, Fundacion Clinica Medica Sur. All rights reserved. The burden of alcoholic liver disease continues to be a major public health problem worldwide. The spectrum of disease ranges from fatty liver to cirrhosis and hepatocellular carcinoma. Alcoholic hepatitis (AH) is a type of acute-on-chronic liver failure and the most severe form of alcoholic liver disease. Severe AH carries a poor short-term prognosis and its management is still challenging, with scarce advances in the last decades. Corticosteroids are still the first line of therapy in severe cases. Unfortunately, many patients do not respond and novel targeted therapies are urgently needed. Liver transplantation has shown extraordinary results in non-responders to corticosteroids however; its applicability is very low. This review summarizes the epidemiology, natural history, risk factors and pathogenesis of alcoholic liver disease with special focus on the latest advances in prognostic stratification and therapy of patients with alcoholic hepatitis.
Original languageEnglish
Pages (from-to)463-473
JournalAnnals of Hepatology
Issue number4
Publication statusPublished - 1 Jul 2016


  • Alcoholic hepatitis
  • Alcoholic liver disease
  • Review
  • Steatohepatitis


Dive into the research topics of 'Alcoholic hepatitis: How far are we and where are we going?'. Together they form a unique fingerprint.

Cite this